Tag: production

•Translational data presented at ADA demonstrate icovamenib’s potential to promote muscle preservation and fat reduction, supporting its broader therapeutic utility in obesity and diabetes, including as a complementary therapy alongside GLP-1 receptor agonists to enhance metabolic health outcomes 
• Clinical data presented at ADA from COVALENT-112 show improvements in HbA1c and C-peptide in type 1 diabetes patients treated with icovamenib, with no evidence of immune activation, and inflammatory markers stable or reduced
• Additionally, the Company expanded its Phase I BMF-650 study to evaluate a rapid one-step titration and enhanced weight loss potential with its oral GLP-1 receptor agonist

TORTOLA, British Virgin Islands, June 05, 2026 (GLOBE NEWSWIRE) -- Orca Energy Group Inc. (“Orca” or the “Company” and includes its subsidiaries and affiliates) (TSX-V: ORC.A, ORC.B) today announces that it has filed its condensed consolidated interim (unaudited) financial statements and management’s discussion and analysis for the three month period ended March 31, 2026 (“Q1 2026”) with the Canadian securities regulatory authorities. All amounts are in United States dollars (“$”) unless otherwise stated.

MONTRÉAL, 05 juin 2026 (GLOBE NEWSWIRE) -- Le CN (TSX : CNR) (NYSE : CNI) a conclu un accord de transport avec BHP pour soutenir le transport de la potasse de la mine de potasse Jansen en Saskatchewan vers les terminaux d’exportation de la côte ouest du Canada, contribuant ainsi à connecter l’un des plus grands nouveaux développements de potasse au monde aux marchés internationaux.

MONTREAL, June 05, 2026 (GLOBE NEWSWIRE) -- CN (TSX: CNR) (NYSE: CNI) has entered into a transportation agreement with BHP to support the movement of potash from the Jansen Potash Mine in Saskatchewan to export terminals on Canada’s West Coast, helping connect one of the world’s largest new potash developments to global markets.